PDUFA | Market Exclusive

Home Tags PDUFA

Two Companies to Watch: Heron Therapeutics Inc (NASDAQ:HRTX) and RedHill Biopharma...

- April 19, 2016 0

Here’s Why a Relypsa Inc (NASDAQ:RLYP) Buyout is Risky Before May...

ME Staff - April 8, 2016 0

Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) Finally Gets an NDA Acceptance for its...

- March 30, 2016 0

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is Preparing to Release PEG-PAL Topline

- March 14, 2016 0

Is the Advanced Accelerator Application SA (ADR) (NASDAQ:AAAP) Delay Cause for...

- February 29, 2016 0

Here are Two Biotech Stocks to Watch in January

Jennifer Aldershot - December 31, 2015 0

Heron’s Big Day Is Just Around The Corner

Jennifer Aldershot - December 23, 2015 0

A Billion Dollar Decision Is Just Around The Corner For Alexion

Roger Hannington - November 24, 2015 0

Biotech 101: Phase 3 Successful, What’s Next?

Jennifer Aldershot - November 5, 2015 0

12Page 2 of 2

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

June 29, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

June 16, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

May 11, 2025

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: PDUFA

Two Companies to Watch: Heron Therapeutics Inc (NASDAQ:HRTX) and RedHill Biopharma...

Here’s Why a Relypsa Inc (NASDAQ:RLYP) Buyout is Risky Before May...

Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) Finally Gets an NDA Acceptance for its...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is Preparing to Release PEG-PAL Topline

Is the Advanced Accelerator Application SA (ADR) (NASDAQ:AAAP) Delay Cause for...

Here are Two Biotech Stocks to Watch in January

Heron’s Big Day Is Just Around The Corner

A Billion Dollar Decision Is Just Around The Corner For Alexion

Biotech 101: Phase 3 Successful, What’s Next?

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY